🇺🇸 FDA
Pipeline program

TREDIMIN 25.000 U.I. /2,5 ml soluzione orale

D AGAINST GVH

Phase 2 small_molecule active

Quick answer

TREDIMIN 25.000 U.I. /2,5 ml soluzione orale for haematologic condition who need staminal cells transplant is a Phase 2 program (small_molecule) at Sana Biotechnology with 1 ClinicalTrials.gov record(s).

Program details

Company
Sana Biotechnology
Indication
haematologic condition who need staminal cells transplant
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials